{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:15:30Z","timestamp":1790144130949,"version":"4.0.1"},"reference-count":262,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.neubiorev.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T08:00:44Z","timestamp":1486800044000},"page":"297-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Energy and the Alzheimer brain"],"prefix":"10.1016","volume":"75","author":[{"given":"Mortimer","family":"Mamelak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2017.02.001_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1469-1809.1984.tb00843.x","article-title":"Advanced grandmaternal age on the mother\u2019s side\u2014a risk of giving rise to trisomy 21","volume":"48","author":"Aagesen","year":"1984","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0010","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nn.2433","article-title":"Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses","volume":"12","author":"Abramov","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jns.2004.11.040","article-title":"Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer\u2019s disease","volume":"229\u2013230","author":"Aliyev","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/neu.2008.0664","article-title":"The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat","volume":"26","author":"Appelberg","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1034\/j.1399-0004.2001.600609.x","article-title":"Familial Down syndrome: evidence supporting cytoplasmic inheritance","volume":"60","author":"Arbuzova","year":"2001","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/bies.10138","article-title":"Mitochondrial dysfunction and Down\u2019s syndrome","volume":"24","author":"Arbuzova","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3104\/reports.88","article-title":"Why is it necessary to study the role of mitochondrial genome in trisomy 21 pathogenesis","volume":"5","author":"Arbuzova","year":"1998","journal-title":"Down Syndr. Res. Pract."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00702-014-1342-8","article-title":"Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer\u2019s disease pathology","volume":"122","author":"Arendt","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0045","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1517\/13543784.2013.812631","article-title":"Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer\u2019s disease","volume":"22","author":"Ashby","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00401-013-1167-9","article-title":"Amyloid and tau: neither chicken nor egg but two partners in crime!","volume":"126","author":"Attems","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer\u2019s disease\u2014lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/BST20120034","article-title":"The relationship between subcortical tau pathology and Alzheimer\u2019s disease","volume":"40","author":"Attems","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrneurol.2010.157","article-title":"Alzheimer disease: caspases first","volume":"6","author":"Avila","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0070","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1128\/AEM.00051-09","article-title":"New insights into {gamma}-aminobutyric acid catabolism: evidence for {gamma}-hydroxybutyric acid and polyhydroxybutyrate synthesis in Saccharomyces cerevisiae","volume":"75","author":"Bach","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1179\/016164104225016272","article-title":"The nature and effects of cortical microvascular pathology in aging and Alzheimer\u2019s disease","volume":"26","author":"Bailey","year":"2004","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.07.010","article-title":"The vascular factor in Alzheimer\u2019s disease: a study in Golgi technique and electron microscopy","volume":"322","author":"Baloyannis","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2006-9204","article-title":"Mitochondrial alterations in Alzheimer\u2019s disease","volume":"9","author":"Baloyannis","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0090","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bcp.2013.10.030","article-title":"Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets","volume":"88","author":"Barone","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ncb1819","article-title":"SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells","volume":"11","author":"Bell","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.fertnstert.2012.11.031","article-title":"The aging oocyte\u2014can mitochondrial function be improved?","volume":"99","author":"Bentov","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0105","first-page":"pe24","article-title":"Presenilins and calcium signaling-systems biology to the rescue","volume":"6","author":"Bezprovzanny","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/scrt440","article-title":"Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models","volume":"5","author":"Blurton-Jones","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12264-013-1424-x","article-title":"Neuronal failure in Alzheimer\u2019s disease: a view through the oxidative stress looking-glass","volume":"30","author":"Bonda","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","article-title":"Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate Abeta1-42\/1-40 ratio in vitro and in vivo","volume":"17","author":"Borchelt","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.20899","article-title":"Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet","volume":"60","author":"Bough","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/0016-5085(90)90982-7","article-title":"The protective effect of gamma-hydroxybutyrate in regional intestinal ischemia in the hamster","volume":"99","author":"Boyd","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/mvre.1994.1028","article-title":"Intestinal microcirculation and leukocyte behavior in ischemia-reperfusion injury","volume":"47","author":"Boyd","year":"1994","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004010050508","article-title":"Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis","volume":"92","author":"Braak","year":"1996","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-011-0825-z","article-title":"Alzheimer\u2019s pathogenesis: is there neuron-to-neuron propagation?","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0160","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/WCO.0b013e32835a3432","article-title":"Where, when, and in what form does sporadic Alzheimer\u2019s disease begin?","volume":"25","author":"Braak","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0165","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00401-013-1170-1","article-title":"Reply: the early pathological process in sporadic Alzheimer\u2019s disease","volume":"126","author":"Braak","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0170","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/brain\/awv236","article-title":"The preclinical phase of the pathological process underlying sporadic Alzheimer\u2019s disease","volume":"138","author":"Braak","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0175","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00293315","article-title":"A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads","volume":"87","author":"Braak","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0180","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0185","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.3233\/JAD-2006-9S305","article-title":"Vulnerability of cortical neurons to Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"9","author":"Braak","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0190","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-013-1139-0","article-title":"Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-beta changes occur before increases of tau in cerebrospinal fluid","volume":"126","author":"Braak","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0200","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2990.2010.01139.x","article-title":"Review: cerebral microvascular pathology in ageing and neurodegeneration","volume":"37","author":"Brown","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00294173","article-title":"Pathological alterations of the cerebral microvasculature in Alzheimer\u2019s disease and related dementing disorders","volume":"87","author":"Buee","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0215","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/378776a0","article-title":"Apoptosis and increased generation of reactive oxygen species in Down\u2019s syndrome neurons in vitro","volume":"378","author":"Busciglio","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0896-6273(02)00604-9","article-title":"Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down\u2019s syndrome","volume":"33","author":"Busciglio","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(01)01630-5","article-title":"Energetic metabolism in mouse cerebral cortex during chronic hypoxia","volume":"301","author":"Caceda","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0230","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.112.195511","article-title":"Hypertension induces brain beta-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature","volume":"60","author":"Carnevale","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0235","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00702-015-1367-7","article-title":"Cerebrovascular and mitochondrial abnormalities in Alzheimer\u2019s disease","volume":"123","author":"Carvalho","year":"2016","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0240","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9440(10)64296-4","article-title":"Microtubule reduction in Alzheimer\u2019s disease and aging is independent of tau filament formation","volume":"162","author":"Cash","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0245","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bcp.2014.01.009","article-title":"The complexities of the pathology-pathogenesis relationship in Alzheimer disease","volume":"88","author":"Castellani","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0250","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s11064-007-9360-7","article-title":"Iron: the Redox-active center of oxidative stress in Alzheimer disease","volume":"32","author":"Castellani","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0255","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3233\/JAD-141074","article-title":"Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer\u2019s disease dementia","volume":"43","author":"Castellano","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0260","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1523\/JNEUROSCI.17-16-06142.1997","article-title":"Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer\u2019s disease: neuropathologic evidence for a mechanism of increased beta-amyloidosis","volume":"17","author":"Cataldo","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","article-title":"Endocytic pathway abnormalities preede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome","volume":"157","author":"Cataldo","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0270","doi-asserted-by":"crossref","first-page":"17288","DOI":"10.1074\/jbc.M111.300483","article-title":"Familial Alzheimer disease presenilin-1 mutations alter the active site conformation of gamma-secretase","volume":"287","author":"Chau","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0275","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0280","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/1568026615666150813142423","article-title":"Targeting insulin signaling for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Chen","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2009.06.060","article-title":"Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson\u2019s disease","volume":"1286","author":"Cheng","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0290","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1212\/WNL.0b013e318246d67a","article-title":"Accelerated cortical atrophy in cognitively normal elderly with high beta-amyloid deposition","volume":"78","author":"Chetelat","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0295","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.neurobiolaging.2014.05.002","article-title":"Use of diuretics is associated with reduced risk of Alzheimer\u2019s disease: the Cache County Study","volume":"35","author":"Chuang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0300","first-page":"1","article-title":"Vascular risk factors and Alzheimer.s disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence \u2013based review","volume":"4","author":"Chui","year":"2012","journal-title":"Alzheimers Res. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.neubiorev.2017.02.001_bib0305","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.3233\/JAD-2010-100351","article-title":"Systemic mitochondrial dysfunction and the etiology of Alzheimer\u2019s disease and Down syndrome dementia","volume":"20","author":"Coskun","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12999","article-title":"Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer\u2019s disease","volume":"1367","author":"Cunnane","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0315","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0065-2911(08)60088-0","article-title":"The role and regulation of energy reserve polymers in micro-organisms","volume":"10","author":"Dawes","year":"1973","journal-title":"Adv. Microb. Physiol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0306-4522(98)00659-9","article-title":"Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment","volume":"91","author":"De Jong","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0141-8130(90)90061-E","article-title":"Biosynthesis and characterization of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) in Alcaligenes eutrophus","volume":"12","author":"Doi","year":"1990","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0330","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1073\/pnas.1121560109","article-title":"Extracting beta-amyloid from Alzheimer\u2019s disease","volume":"109","author":"Dries","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0335","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0197-4580(97)00047-X","article-title":"Prevalence, incidence and duration of Braak\u2019s stages in the general population: can we know?","volume":"18","author":"Duyckaerts","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0340","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","article-title":"PART is part of Alzheimer disease","volume":"129","author":"Duyckaerts","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0345","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0350","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.STR.0000153067.27288.8b","article-title":"Oxidative stress: the curse that underlies cerebral vascular dysfunction?","volume":"36","author":"Faraci","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0355","doi-asserted-by":"crossref","first-page":"H1566","DOI":"10.1152\/ajpheart.01310.2010","article-title":"Protecting against vascular disease in brain","volume":"300","author":"Faraci","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0360","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neurobiolaging.2014.10.025","article-title":"Commentary: is Alzheimer\u2019s disease uniquely human?","volume":"36","author":"Finch","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0365","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/BF00294246","article-title":"Altered angioarchitecture in selected areas of brains with Alzheimer\u2019s disease","volume":"79","author":"Fischer","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0370","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrn2786","article-title":"Prion-like mechanisms in neurodegenerative diseases","volume":"11","author":"Frost","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0375","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2990.2010.01135.x","article-title":"Granulovacuolar degeneration (GVD) bodies of Alzheimer\u2019s disease (AD) resemble late-stage autophagic organelles","volume":"37","author":"Funk","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0380","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2353\/ajpath.2010.090482","article-title":"Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer\u2019s disease mutations","volume":"176","author":"Gama Sosa","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0385","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.lfs.2013.08.017","article-title":"Systemic oxidative stress in children and teenagers with Down syndrome","volume":"93","author":"Garlet","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0390","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1093\/gerona\/52A.2.M117","article-title":"Heritability for Alzheimer\u2019s disease: the study of dementia in Swedish twins","volume":"52","author":"Gatz","year":"1997","journal-title":"J. Gerontol. Ser. A-Biol. Sci. Med. Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0395","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10522-014-9515-2","article-title":"Mitochondrial function and mitochondrial DNA maintenance with advancing age","volume":"15","author":"Gaziev","year":"2014","journal-title":"Biogerontology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0400","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/exnr.1998.6860","article-title":"High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer\u2019s disease-related neurofibrillary changes","volume":"153","author":"Ghebremedhin","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0405","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.biopsych.2010.05.030","article-title":"Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer\u2019s disease progression","volume":"68","author":"Ginsburg","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0410","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neurobiolaging.2013.06.011","article-title":"Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly","volume":"35","author":"Glodzik","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0415","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bcp.2013.11.010","article-title":"Mitochondrial respiration as a target for neuroprotection and cognitive enhancement","volume":"88","author":"Gonzalez-Lima","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0420","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/S1462399411001918","article-title":"Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases","volume":"13","author":"Grammas","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0425","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/jcbfm.1990.91","article-title":"Effect of gamma-hydroxybutyrate on local and global glucose metabolism in the anesthetized cat brain","volume":"10","author":"Haller","year":"1990","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0430","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0435","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1194\/jlr.R046599","article-title":"Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester","volume":"55","author":"Hashim","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0440","first-page":"E746","article-title":"Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia","volume":"270","author":"Hasselbalch","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0445","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","article-title":"Adaptive downregulation of mitochondrial function in Down syndrome","volume":"17","author":"Helguera","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0450","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2350-12-137","article-title":"Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer\u2019s disease; a randomized, double-blind, placebo-controlled study","volume":"12","author":"Henderson","year":"2011","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0455","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1743-7075-6-31","article-title":"Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer\u2019s disease: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"6","author":"Henderson","year":"2009","journal-title":"Nutr. Metab (Lond.)"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0460","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/brain\/awt308","article-title":"Sustained peripheral depletion of amyloid-\u03b2 with a novel form of neprilysin does not affect central levels of amyloid-\u03b2","volume":"137","author":"Henderson","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0465","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jnc.13107","article-title":"Effects of ketone bodies in Alzheimer\u2019s disease in relation to neural hypometabolism, beta-amyloid toxicity, and astrocyte function","volume":"134","author":"Hertz","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0470","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer\u2019s disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0475","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0480","doi-asserted-by":"crossref","first-page":"20978","DOI":"10.1074\/jbc.M500526200","article-title":"Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron","volume":"280","author":"Honda","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0485","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00401-005-1038-0","article-title":"The unfolded protein response is activated in Alzheimer\u2019s disease","volume":"110","author":"Hoozemans","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0490","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2353\/ajpath.2009.080814","article-title":"The unfolded protein response is activated in pretangle neurons in Alzheimer\u2019s disease hippocampus","volume":"174","author":"Hoozemans","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0495","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006361","article-title":"The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease","volume":"2","author":"Ihara","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0500","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bcp.2014.01.002","article-title":"Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles","volume":"88","author":"Iqbal","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0505","doi-asserted-by":"crossref","first-page":"e1003974","DOI":"10.1371\/journal.pgen.1003974","article-title":"Oxidative stress is not a major contributor to somatic mitochondrial DNA mutations","volume":"10","author":"Itsara","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0510","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain beta-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0515","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/WNL.0000000000000386","article-title":"Rates of beta-amyloid accumulation are independent of hippocampal neurodegeneration","volume":"82","author":"Jack","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0520","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1471-4159.2008.05460.x","article-title":"The ketogenic diet increases mitochondrial glutathione levels","volume":"106","author":"Jarrett","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0525","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2337\/db12-0025","article-title":"Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans","volume":"61","author":"Jauch-Chara","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0530","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-015-1407-2","article-title":"PART, a distinct tauopathy, different from classical sporadic Alzheimer disease","volume":"129","author":"Jellinger","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0535","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbadis.2013.09.007","article-title":"Mitochondria-targeted antioxidants for treatment of Parkinson\u2019s disease: preclinical and clinical outcomes","volume":"1842","author":"Jin","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0540","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.21223","article-title":"Beta-amyloid burden is not associated with rates of brain atrophy","volume":"63","author":"Josephs","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0545","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0891-5849(98)00137-3","article-title":"Biomarkers of oxidative stress are significantly elevated in Down syndrome","volume":"25","author":"Jovanovic","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0550","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/jcbfm.2015.1","article-title":"Protection of hypoglycemia-induced neuronal death by \u03b2-hydroxybutyrate involves preservation of energy levels and decreased production of reactive oxygen species","volume":"35","author":"Julio-Amilpas","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0555","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","article-title":"D-beta-hydroxybutyrate protects neurons in models of Alzheimer\u2019s and Parkinson\u2019s disease","volume":"97","author":"Kashiwaya","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0560","doi-asserted-by":"crossref","first-page":"25950","DOI":"10.1074\/jbc.M110.138198","article-title":"A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat","volume":"285","author":"Kashiwaya","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0565","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.neurobiolaging.2012.11.023","article-title":"A ketone ester diet exhibits anxiolytic and cognition-sparing properties: and lessens amyloid and tau pathologies in a mouse model of Alzheimer\u2019s disease","volume":"34","author":"Kashiwaya","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0570","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0015-0282(16)57796-6","article-title":"Mitochondrial deoxyribonucleic acid deletions in oocytes and reproductive aging in women","volume":"64","author":"Keefe","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0575","first-page":"197","article-title":"Evidence of endothelial dysfunction in the development of Alzheimer\u2019s disease: is Alzheimer\u2019s a vascular disorder?","volume":"3","author":"Kelleher","year":"2013","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0580","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40263-014-0147-5","article-title":"Cognitive effects of statin medications","volume":"28","author":"Kelley","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0585","doi-asserted-by":"crossref","first-page":"e1003794","DOI":"10.1371\/journal.pgen.1003794","article-title":"Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage","volume":"9","author":"Kennedy","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0590","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2009.04.013","article-title":"Pharmacological doses of gamma-hydroxybutyrate (GHB) potentiate histone acetylation in the rat brain by histone deacetylase inhibition","volume":"57","author":"Klein","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0595","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neurobiolaging.2014.10.003","article-title":"gamma-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer\u2019s disease","volume":"36","author":"Klein","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0600","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/WNL.0000000000000438","article-title":"beta-Amyloidosis and neurodegeneration in Alzheimer disease: who\u2019s on first?","volume":"82","author":"Knopman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0605","first-page":"275","article-title":"Cardioprotective action of sodium gamma-hydroxybutyrate against isoproterenol induced myocardial damage","volume":"74","author":"Kolin","year":"1993","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0610","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/joim.12055","article-title":"The role of mitochondrial DNA mutations and free radicals in disease and ageing","volume":"273","author":"Lagouge","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0615","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/hipo.20730","article-title":"Developmental regulation of gene expression and astrocytic processes may explain selective hippocampal vulnerability","volume":"21","author":"Lavenex","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0620","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1227\/00006123-198304000-00010","article-title":"Effect of low dose gamma-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained, awake rat","volume":"12","author":"Lavyne","year":"1983","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0625","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.expneurol.2005.01.026","article-title":"Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms","volume":"194","author":"Lee","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0630","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000056744.26901.BA","article-title":"Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide","volume":"23","author":"Leopold","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0635","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1073\/pnas.0609303104","article-title":"Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer\u2019s neurodegeneration","volume":"104","author":"Li","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0640","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0645","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer\u2019s disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0650","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-60327-029-8_8","article-title":"Nanoparticle and iron chelators as a potential novel Alzheimer therapy","volume":"610","author":"Liu","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0655","doi-asserted-by":"crossref","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","article-title":"Trans-synaptic spread of tau pathology in vivo","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0660","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","article-title":"Function and regulation of CREB family transcription factors in the nervous system","volume":"35","author":"Lonze","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0665","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer\u2019s disease","volume":"131","author":"Love","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0670","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bpa.12401","article-title":"Cerebral hypoperfusion and the energy deficit in Alzheimer\u2019s disease","volume":"26","author":"Love","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0675","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-8993(78)90229-9","article-title":"The effects of gamma-hydroxybutyrate and gamma-butyrolactone upon the energy metabolism of the normoxic and hypoxic rat brain","volume":"146","author":"MacMillan","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0680","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","article-title":"Apolipoprotein e sets the stage: response to injury triggers neuropathology","volume":"76","author":"Mahley","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0685","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-016-0205-y","article-title":"A proposed preventive role for gamma-hydroxybutyrate (Xyrem) in Alzheimer\u2019s disease","volume":"8","author":"Maitre","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0690","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2350-7-4","article-title":"Influence of advanced age of maternal grandmothers on Down syndrome","volume":"7","author":"Malini","year":"2006","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0695","series-title":"Gammahydroxybutryate: Molecular, Functional and Clinical Aspects","first-page":"218","article-title":"\u03b3-Hydroxybutyrate and oxidative stress","author":"Mamelak","year":"2002"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0700","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neurobiolaging.2006.06.008","article-title":"Alzheimer\u2019 s disease, oxidative stress and gammahydroxybutyrate","volume":"28","author":"Mamelak","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0705","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pneurobio.2009.07.004","article-title":"Narcolepsy and depression and the neurobiology of gammahydroxybutyrate","volume":"89","author":"Mamelak","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0710","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-2012-120370","article-title":"Sporadic Alzheimer\u2019s disease: the starving brain","volume":"31","author":"Mamelak","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0715","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00401-013-1162-1","article-title":"Amyloid or tau: the chicken or the egg?","volume":"126","author":"Mann","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0720","series-title":"Molecular Mechanisms of Metabolic Arrest: Life in Limbo","first-page":"23","article-title":"Hibernation, a state of profound intolerance to profound reduction in organ blood flow and oxygen delivery capacity","author":"McCarron","year":"2001"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0725","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/NEN.0b013e3181a9d503","article-title":"Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury","volume":"68","author":"McKee","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0730","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bpa.12248","article-title":"The neuropathology of chronic traumatic encephalopathy","volume":"25","author":"McKee","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0735","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","article-title":"Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u2019s disease","volume":"1822","author":"Mecocci","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0740","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer\u2019s disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0745","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bpa.12331","article-title":"Pathophysiology of hypoperfusion of the precuneus in early Alzheimer\u2019s disease","volume":"26","author":"Miners","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0750","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0755","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaneurol.2014.4636","article-title":"Vascular plasticity and cognition during normal aging and dementia","volume":"72","author":"Montagne","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0760","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0765","first-page":"437","article-title":"Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer\u2019s disease is associated with inheritance of APOE4","volume":"150","author":"Montine","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0770","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1212\/01.wnl.0000192307.15103.83","article-title":"Brain and brawn: parallels in oxidative strength","volume":"66","author":"Moreira","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0775","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2013.12.018","article-title":"The role of amyloid-beta in the regulation of memory","volume":"88","author":"Morley","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0780","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/ana.410440706","article-title":"Determinants of neuronal vulnerability in neurodegenerative diseases","volume":"44","author":"Morrison","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0785","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.tcb.2013.07.007","article-title":"Oligodendroglia: metabolic supporters of axons","volume":"23","author":"Morrison","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0790","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","article-title":"Reduced hippocampal metabolism in MCI and AD: automated FDG-Pet image analysis","volume":"64","author":"Mosconi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0795","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-4-3-170","article-title":"Maternal transmission of Alzheimer\u2019s disease: prodromal metabolic phenotype and the search for genes","volume":"4","author":"Mosconi","year":"2010","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0800","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2011-110866","article-title":"Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer\u2019s disease","volume":"27","author":"Mosconi","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0805","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-079X.2012.00984.x","article-title":"Melatonin protects against isoproterenol-induced alterations in cardiac mitochondrial energy-metabolizing enzymes, apoptotic proteins, and assists in complete recovery from myocardial injury in rats","volume":"53","author":"Mukherjee","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0810","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1046\/j.1471-4159.1999.0722323.x","article-title":"The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin","volume":"72","author":"Neely","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0815","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0820","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","article-title":"Ketone bodies as signaling metabolites","volume":"25","author":"Newman","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0825","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2014.01.006","article-title":"A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer\u2019s disease","volume":"11","author":"Newport","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0830","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1242\/jcs.01192","article-title":"Redox state regulates HIF-!alpha and its DNA binding and phosphorylation in salmonid cells","volume":"117","author":"Nikinmaa","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0835","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molbrainres.2004.06.020","article-title":"A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet","volume":"129","author":"Noh","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0840","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.neurobiolaging.2013.11.027","article-title":"Brain glucose and acetoacetate metabolism: a comparison of young and older adults","volume":"35","author":"Nugent","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0845","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1749-6632.1999.tb07855.x","article-title":"Neuronal RNA oxidation in Alzheimer\u2019s disease and Down\u2019s syndrome","volume":"893","author":"Nunomura","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0850","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jnen\/59.11.1011","article-title":"Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome","volume":"59","author":"Nunomura","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0855","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0860","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-009-0508-1","article-title":"RNA oxidation in Alzheimer disease and related neurodegenerative disorders","volume":"118","author":"Nunomura","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0865","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/NEN.0b013e318248e614","article-title":"The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons","volume":"71","author":"Nunomura","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0870","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1007\/s00018-009-0141-0","article-title":"Contribution of hypoxia to Alzheimer\u2019s disease: is HIF-1\u03b1 a mediator of neurodegeneration?","volume":"66","author":"Ogunshola","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0875","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(03)03252-9","article-title":"Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage","volume":"986","author":"Ottani","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0880","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI105650","article-title":"Brain metabolism during fasting","volume":"46","author":"Owen","year":"1967","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0885","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3233\/JAD-130383","article-title":"Endothelin-converting enzyme-1 activity, endothelin-1-production and fee radical-dependent vasoconstriction in Alzheimer\u2019s disease","volume":"36","author":"Palmer","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0890","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/hmg\/dds529","article-title":"Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects","volume":"22","author":"Piccoli","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0895","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1179\/1476830510Y.0000000001","article-title":"Mild experimental ketosis increases brain uptake of 11C-acetoacetate and 18F-fluorodeoxyglucose: a dual-tracer PET imaging study in rats","volume":"14","author":"Pifferi","year":"2011","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0900","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1523\/JNEUROSCI.23-13-05531.2003","article-title":"The production of amyloid beta peptide is a critical requirement for the viability of central neurons","volume":"23","author":"Plant","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0905","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0306-4522(92)90337-2","article-title":"Hibernation-induced structural changes in synaptic contacts between mossy fibres and hippocampal pyramidal neurons","volume":"48","author":"Popov","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0910","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0306-4522(92)90336-Z","article-title":"Repeated changes of dendritic morphology in the hippocampus of ground squirrels in the course of hibernation","volume":"48","author":"Popov","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0915","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and preclinical Alzheimer\u2019s disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0920","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/jcbfm.2008.79","article-title":"Neuroprotection in diet-induced ketotic rat brain after focal ischemia","volume":"28","author":"Puchowicz","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0925","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0753-3322(97)86906-5","article-title":"Alzheimer\u2019s disease in twins","volume":"5","author":"Raiha","year":"1997","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0930","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0278-5846(03)00020-4","article-title":"Apoptotic promoters and inhibitors in Alzheimer\u2019s disease: who wins out?","volume":"27","author":"Raina","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0935","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0891-5849(99)00102-1","article-title":"Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer\u2019s disease is related to the apolipoprotein E genotype","volume":"27","author":"Ramassamy","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0940","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.410420406","article-title":"Autosomal dominant dementia with widespread neurofibrillary tangles","volume":"42","author":"Reed","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0945","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","article-title":"Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer\u2019s disease","volume":"98","author":"Reiman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0950","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0955","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","article-title":"Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers","volume":"88","author":"Reitz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0960","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2006.03.056","article-title":"gamma-Hydroxybutyrate induces cyclic AMP-responsive element-binding protein phosphorylation in mouse hippocampus: an involvement of GABA(B) receptors and cAMP-dependent protein kinase activation","volume":"141","author":"Ren","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0965","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/dmd.111.041749","article-title":"Brain uptake of the drug of abuse gamma-hydroxybutyric acid in rats","volume":"40","author":"Roiko","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0970","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.20493","article-title":"Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study","volume":"57","author":"Ruitenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0975","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1196\/annals.1369.054","article-title":"Gamma-hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion","volume":"1074","author":"Sadasivan","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0980","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s004010050968","article-title":"Entorhinal cortex of aged subjects with Down\u2019s syndrome shows severe neuronal loss caused by neurofibrillary pathology","volume":"97","author":"Sadowski","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0985","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jnr.22670","article-title":"From the liver to the blood-brain barrier: an interconnected system regulating brain amyloid-beta levels","volume":"89","author":"Sagare","year":"2011","journal-title":"J. Neurosci. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2017.02.001_bib0990","first-page":"S87","article-title":"Neurovascular defects and faulty amyloid-beta vascular clearance in Alzheimer\u2019s disease","volume":"33","author":"Sagare","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib0995","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07331.x","article-title":"AMP-activated protein kinase: a potential player in Alzheimer\u2019s disease","volume":"118","author":"Salminen","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1000","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.2010.06645.x","article-title":"Chronic in vitro ketosis is neuroprotective but not anti-convulsant","volume":"113","author":"Samoilova","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1005","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","article-title":"4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer\u2019s disease","volume":"68","author":"Sayre","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mcn.2012.07.011","article-title":"Mitochondria-associated ER membranes in Alzheimer disease","volume":"55","author":"Schon","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.neubiorev.2017.02.001_bib1020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/15.suppl_2.160","article-title":"Chromosomal non-disjunction in human oocytes: is there a mitochondrial connection?","volume":"15","author":"Schon","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(94)91398-6","article-title":"Increased risk of Alzheimer\u2019s disease in mothers of adults with Down\u2019s syndrome","volume":"344","author":"Schupf","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1030","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1212\/WNL.57.6.979","article-title":"Specificity of the fivefold increase in AD in mothers of adults with Down syndrome","volume":"57","author":"Schupf","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1035","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1073\/pnas.1112209109","article-title":"Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver","volume":"109","author":"Sehgal","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1750-3639.2010.00469.x","article-title":"Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer\u2019s disease","volume":"21","author":"Sepulveda-Falla","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1045","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI66407","article-title":"Familial Alzheimer\u2019s disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis","volume":"124","author":"Sepulveda-Falla","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0006-8993(94)90815-X","article-title":"Delayed treatment with 1,3-butanediol reduces loss of CA1 neurons in the hippocampus of rats following brief forebrain ischemia","volume":"662","author":"Sims","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1060","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.55.7.964","article-title":"Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study","volume":"55","author":"Slooter","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1065","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0891-5849(02)01021-3","article-title":"Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain","volume":"33","author":"Smith","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1070","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain infarction and the clinical expression of Alzheimer disease. The Nun Study","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0896-6273(03)00367-2","article-title":"The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide","volume":"39","author":"Soucek","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neurobiolaging.2009.04.016","article-title":"Advanced glycation endproducts and their receptor RAGE in Alzheimer\u2019s disease","volume":"32","author":"Srikanth","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1085","series-title":"Integrative Physiology: in the Proteomics and Post-genomic Age","first-page":"169","article-title":"Biochemical adaptation to extreme environments","author":"Story","year":"2005"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1090","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/j.1471-4159.2008.05294.x","article-title":"Physiological regulation of tau phosphorylation during hibernation","volume":"105","author":"Su","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neulet.2009.11.010","article-title":"Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells","volume":"468","author":"Su","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2017.02.001_bib1100","first-page":"S243","article-title":"Oxidative modification of brain proteins in Alzheimer\u2019s disease: perspective on future studies based on results of redox proteomics studies","volume":"33","author":"Sultana","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1105","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1007\/s11064-008-9593-0","article-title":"Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment","volume":"33","author":"Sultana","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1110","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/jnr.22603","article-title":"Peripheral reduction of beta-amyloid is sufficient to reduce brain beta-amyloid: implications for Alzheimer\u2019s disease","volume":"89","author":"Sutcliffe","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1254\/jjp.87.143","article-title":"Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats","volume":"87","author":"Suzuki","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1254\/jjp.89.36","article-title":"Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia","volume":"89","author":"Suzuki","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1125","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer\u2019s disease metabolic cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1130","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.bbabio.2012.02.028","article-title":"Effect of mtDNA point mutations on cellular bioenergetics","volume":"1817","author":"Szczepanowska","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1135","first-page":"192","article-title":"Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies","volume":"45","author":"Szpak","year":"2007","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm0196-93","article-title":"Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down\u2019s syndrome","volume":"2","author":"Teller","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1150","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00005072-199655100-00001","article-title":"The pathogenesis of Alzheimer\u2019s disease: an alternative to the amyloid hypothesis","volume":"55","author":"Terry","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-7091-6467-9_12","article-title":"The cytoskeleton in Alzheimer disease","volume":"53","author":"Terry","year":"1998","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1160","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI200318797","article-title":"D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease","volume":"112","author":"Tieu","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.neubiorev.2017.02.001_bib1165","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000238","article-title":"Targeting Alzheimer\u2019s disease neuro-metabolic dysfunction with a small molecule nuclear receptor agonist (T3D-959) reverses disease pathologies","volume":"6","author":"Tong","year":"2016","journal-title":"J. Alzheimers Dis. Parkinsonism"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-7075-2-28","article-title":"A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer\u2019s disease","volume":"2","author":"Van der Auwera","year":"2005","journal-title":"Nutr. Metab. (London)"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1175","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.metabol.2014.10.033","article-title":"Biomarkers, ketone bodies, and the prevention of Alzheimer\u2019s disease","volume":"64","author":"VanItallie","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2003.09.007","article-title":"The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism","volume":"70","author":"Veech","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1190","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00401-010-0759-x","article-title":"AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer\u2019s disease and other tauopathies","volume":"121","author":"Vingtdeux","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/exnr.2001.7630","article-title":"PP2A mRNA expression is quantitatively decreased in Alzheimer\u2019s disease hippocampus","volume":"168","author":"Vogelsberg-Ragaglia","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1205","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","article-title":"Microtubule-associated protein tau in development, degeneration and protection of neurons","volume":"85","author":"Wang","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1210","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2003.09.003","article-title":"Oxidized neprilysin in aging and Alzheimer\u2019s disease brains","volume":"310","author":"Wang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1215","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.04-3182fje","article-title":"Calorie restriction attenuates \u03b2- amyloid neuropathology in mouse model of Alzheimer\u2019s disease","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s12264-013-1415-y","article-title":"Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer\u2019s disease","volume":"30","author":"Wang","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1225","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1230","first-page":"245","article-title":"Gamma-hydroxybutyrate protects the liver from warm ischemia-reperfusion injury in rat","volume":"3","author":"Wei","year":"2004","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1235","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2013.12.067","article-title":"Gamma-hydroxybutyrate, acting through an anti-apoptotic mechanism, protects native and amyloid-precursor-protein-transfected neuroblastoma cells against oxidative stress-induced death","volume":"263","author":"Wendt","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1240","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/01.wnl.0000324924.91351.7d","article-title":"MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study","volume":"71","author":"Whitwell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1245","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-142874","article-title":"Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer\u2019s disease","volume":"44","author":"Wischik","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1250","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bcp.2013.12.020","article-title":"Immunotherapy for Alzheimer\u2019s disease","volume":"88","author":"Wisniewski","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1255","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nm1287","article-title":"Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease","volume":"11","author":"Wu","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1260","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","article-title":"Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons","volume":"288","author":"Wu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1265","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1270","doi-asserted-by":"crossref","first-page":"e21788","DOI":"10.1371\/journal.pone.0021788","article-title":"2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer\u2019s disease","volume":"6","author":"Yao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1275","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp-2012-303144","article-title":"Therapeutic strategies for tau mediated neurodegeneration","volume":"84","author":"Yoshiyama","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1280","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2006.04.167","article-title":"Age-dependent oxidative stress-induced DNA damage in Down\u2019s lymphocytes","volume":"345","author":"Zana","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1285","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1016\/j.biomaterials.2013.06.043","article-title":"3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer\u2019s disease via mitochondria protection mechanism","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1290","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.R800009200","article-title":"Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure","volume":"284","author":"Zhong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1295","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jns.2007.01.039","article-title":"Vascular oxidative stress in Alzheimer disease","volume":"257","author":"Zhu","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1300","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","article-title":"Clearing amyloid through the blood-brain barrier","volume":"89","author":"Zlokovic","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1305","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2017.02.001_bib1310","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","article-title":"Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease","volume":"70","author":"Zlokovic","year":"2013","journal-title":"JAMA Neurol."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976341630690X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976341630690X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T15:39:58Z","timestamp":1568821198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014976341630690X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":262,"alternative-id":["S014976341630690X"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2017.02.001","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Energy and the Alzheimer brain","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}